Catalyst Wire Dossier Catalyst Wire Dossier

BIWB 2

· Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BIWB 2, covering 2014-07-31 to 2014-07-31. Get the full timeline:

Most recent: Clinical Trial Update: Dose Escalation Study to Evaluate Safety and Tolerability of an Allogeneic Tumor Vaccine BIWB 2 in Patients With Advanced Malignant Melanoma [Phase 1]

See pricing